We present a selection of interesting news and research for the month of May focusing on type 2 diabetes. See the slide legends for links to the article summaries.
Interesting T2DM: FDA News & Diabetes Risk. May 2017
Serum Lipidomics Reveals Early Differential Effects of Gastric Bypass Compared With Banding on Phospholipids and Sphingolipids Independent of Differences in Weight Loss. Abstract link. **** Mental Illness in Bariatric Surgery: A Cohort Study From the PORTAL Network. Abstract link.
Early Glycemic Control and Magnitude of HbA1c Reduction Predict Cardiovascular Events and Mortality: Population-Based Cohort Study of 24,752 Metformin Initiators. Abstract link. **** Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease. Abstract link.
Global Economic Burden of Diabetes and Its Implications. Abstract link. **** Statin Therapy Reduces Future Risk of Lower Limb Amputation in Patient With Diabetes and Peripheral Artery Disease. Abstract link.
Diabetes Among Non-Obese Filipino Americans: Findings From a Large Population-Based Study. Abstract link. **** Endocrine Comorbidities in Patients With Psoriatic Arthritis: A Population-Based Case-Controlled Study. Abstract link.
Amalgam Rx Unveils iSage Rx, the First FDA-Cleared Application for Titration of All Brands of Basal Insulin. Press release. **** FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy, the Leading Cause of Blindness Among Working Age Adults in the United States. Press release.
A Nurse-Led Education and Cognitive Behaviour Therapy-Based Intervention Among Adults With Uncontrolled Type 2 Diabetes: A Randomised Controlled Trial. Abstract link. **** Long-term Cost Reduction of Routine Medications Following a Residential Programme Combining Physical Activity and Nutrition in the Treatment of Type 2 Diabetes: A Prospective Cohort Study. Abstract link.
Upper and/or Lower Gastrointestinal Adverse Events With Glucagon-Like Peptide-1 Receptor Agonists: Incidence and Consequences. Abstract link. **** Rates of Hypoglycaemia Are Lower in Patients Treated With Insulin Degludec/Liraglutide (IDegLira) Than With IDeg or Insulin Glargine Regardless of the Hypoglycaemia Definition Used. Abstract link.
Brain Changes in Overweight/Obese and Normal-Weight Adults With Type 2 Diabetes Mellitus. Abstract link. **** Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. Abstract link.
Modeling the Economic and Health Impact of Increasing Children’s Physical Activity in the United States. Abstract link. **** Genome-Wide Physical Activity Interactions in AdiposityâA Meta-analysis of 200,452 Adults. Abstract link.
